KUBOTA PHARMACEUTICAL HOLDINGS CO LTD Research and Development Expense
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD reported Research and Development Expense of $4.88 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2017-05-10
- KUBOTA PHARMACEUTICAL HOLDINGS CO LTD research and development expense for the quarter ending 2017-03-31 was $4.88M, a 45.31% decline year-over-year.
- KUBOTA PHARMACEUTICAL HOLDINGS CO LTD research and development expense for the quarter ending 2016-12-31 was $3.38M, a 30.67% decline year-over-year.
- KUBOTA PHARMACEUTICAL HOLDINGS CO LTD research and development expense for the quarter ending 2016-09-30 was $4.01M, a 35.92% decline year-over-year.
- KUBOTA PHARMACEUTICAL HOLDINGS CO LTD research and development expense for the quarter ending 2016-06-30 was $4.40M, a 21.99% decline year-over-year.
- KUBOTA PHARMACEUTICAL HOLDINGS CO LTD research and development expense for fiscal 2016 was $20.71M, a 8.52% decline from fiscal 2015.
- KUBOTA PHARMACEUTICAL HOLDINGS CO LTD research and development expense for fiscal 2015 was $22.64M, a 11.52% decline from fiscal 2014.
- KUBOTA PHARMACEUTICAL HOLDINGS CO LTD research and development expense for fiscal 2014 was $25.58M, a 29.73% decline from fiscal 2013.
- KUBOTA PHARMACEUTICAL HOLDINGS CO LTD research and development expense for fiscal 2013 was $36.41M, a 15.19% increase from fiscal 2012.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2017-03-31 | $4.88M 10-Q · filed 2017-05-10 | $8.26M derived: sum of 2 quarters · filed 2017-05-10 | $12.26M derived: sum of 3 quarters · filed 2017-05-10 | $16.67M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-12-31 | $3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $7.39M derived: sum of 2 quarters · filed 2017-03-15 | $11.79M derived: sum of 3 quarters · filed 2017-03-15 | $20.71M 10-K · filed 2017-03-15 |
| 2016-09-30 | $4.01M 10-Q · filed 2016-11-04 | $8.41M derived: sum of 2 quarters · filed 2016-11-04 | $17.33M 10-Q · filed 2016-11-04 | $22.20M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-06-30 | $4.40M 10-Q · filed 2016-08-08 | $13.32M 10-Q · filed 2016-08-08 | $18.19M derived: sum of 3 quarters · filed 2017-05-10 | $24.45M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-03-31 | $8.92M 10-Q · filed 2017-05-10 | $13.79M derived: sum of 2 quarters · filed 2017-05-10 | $20.05M derived: sum of 3 quarters · filed 2017-05-10 | $25.69M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $4.87M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $11.13M derived: sum of 2 quarters · filed 2017-03-15 | $16.77M derived: sum of 3 quarters · filed 2017-03-15 | $22.64M 10-K · filed 2017-03-15 |
| 2015-09-30 | $6.25M 10-Q · filed 2016-11-04 | $11.90M derived: sum of 2 quarters · filed 2016-11-04 | $17.76M 10-Q · filed 2016-11-04 | $23.37M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $5.64M 10-Q · filed 2016-08-08 | $11.51M 10-Q · filed 2016-08-08 | $17.12M derived: sum of 3 quarters · filed 2017-03-15 | $22.62M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | $5.87M 10-Q · filed 2016-05-10 | $11.47M derived: sum of 2 quarters · filed 2017-03-15 | $16.98M derived: sum of 3 quarters · filed 2017-03-15 | $23.48M derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | $5.61M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $11.11M derived: sum of 2 quarters · filed 2017-03-15 | $17.61M derived: sum of 3 quarters · filed 2017-03-15 | $25.58M 10-K · filed 2017-03-15 |
| 2014-09-30 | $5.50M 10-Q · filed 2015-11-13 | $12.00M derived: sum of 2 quarters · filed 2015-11-13 | $19.97M 10-Q · filed 2015-11-13 | $30.16M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | $6.50M 10-Q · filed 2015-08-07 | $14.47M 10-Q · filed 2015-08-07 | $24.66M derived: sum of 3 quarters · filed 2016-03-11 | $34.90M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | $7.97M 10-Q · filed 2015-05-14 | $18.15M derived: sum of 2 quarters · filed 2016-03-11 | $28.40M derived: sum of 3 quarters · filed 2016-03-11 | $36.25M derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | $10.18M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $20.43M derived: sum of 2 quarters · filed 2016-03-11 | $28.28M derived: sum of 3 quarters · filed 2016-03-11 | $36.41M 10-K · filed 2016-03-11 |
| 2013-09-30 | $10.25M 10-Q · filed 2014-11-14 | $18.09M derived: sum of 2 quarters · filed 2014-11-14 | $26.22M 10-Q · filed 2014-11-14 | |
| 2013-06-30 | $7.84M 10-Q · filed 2014-08-14 | $15.97M 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | $8.13M 10-Q · filed 2014-05-15 | |||
| 2012-12-31 | $31.60M 10-K · filed 2015-03-30 |